☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Nanobiotix
NANOBIOTIX Signs a License Agreement with Janssen to Co-Develop and Commercialize NBTXR3
July 10, 2023
Nanobiotix Initiates US Patient Enrollment of P-III Trial (NANORAY-312) for Head and Neck Cancer
December 27, 2022
PharmaShots Interview: Laurent Levy, CEO of Nanobiotix Shares Insights and Clinical Updates on its Nanoparticle Therapy
August 10, 2022
PharmaShots Interview: In Conversation with Leonard A. Farber and James Welsh, Where they Share Insights on How Nanoparticle can T...
June 15, 2022
PharmaShots Weekly Snapshots (May 10 - 14, 2021)
May 14, 2021
PharmaShots Weekly Snapshots (Jan 18 - 22, 2021)
January 22, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.